Patent Oppositions in medical and personal care products industry

Explore the competitive field of medical and personal care products where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in medical and personal care products technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Last updated on: Jun 4, 2026
CompanyTotal Oppositions
GENERICS UK211
TEVA PHARMACEUTICALS209
STRAWMAN137
SANDOZ118
STADA ARZNEIMITTEL98
HAMM & WITTKOPP89
NUTRICIA79
MAIWALD70
HOFFMANN EITLE66
NESTLE63

Explore the top companies that have faced the most patent oppositions in the technology industry.

Last updated on: Jun 4, 2026
CompanyTotal Oppositions
NOVARTIS318
BOEHRINGER INGELHEIM173
NOVO NORDISK109
GLAXOSMITHKLINE108
AMGEN104
PFIZER88
NUTRICIA87
NESTLE81
F HOFFMANN LA ROCHE76
NESTEC69

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the medical and personal care products industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the medical and personal care products industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jun 4, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Methods Of Treating Chronic Kidney Disease With DapagliflozinASTRAZENECAMay 12, 2026SANDOZ
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKMay 6, 2026GEDEON RICHTER
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKMay 5, 2026ZENTIVA
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKApr 28, 2026SANDOZ
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKApr 19, 2026TEVA PHARMACEUTICALS
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHEApr 16, 2026STORZ
Methods Of Treating Fabry Patients Having Renal ImpairmentAMICUS THERAPEUTICSApr 15, 2026TEVA PHARMACEUTICALS
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKApr 13, 2026ELKINGTON AND FIFE
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression Innpm1MEMORIAL SLOAN KETTERING CANCER CENTERApr 9, 2026ARROWHOUSE
Oxytocin Receptor Antagonist Therapy In The Luteal Phase For Implantation And Pregnancy In Women Undergoing Assisted Reproductive TechnologiesFERRINGApr 9, 2026JAMES POOLE

To stay ahead in the competitive medical and personal care products industry, companies are constantly innovating. Here are the top patents facing oppositions in the medical and personal care products industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jun 4, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Oct 12, 2022S1P Receptor Modulators For Treating Multiple SclerosisNOVARTIS23
Apr 14, 2021Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGY22
Nov 6, 2024Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA20
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM19
Aug 6, 2025Use Of Long-Acting Glp-1 PeptidesNOVO NORDISK18
Oct 23, 2024New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTIS18
Oct 11, 2023New UseNOVARTIS17
Jan 16, 2019(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofAMGEN EUROPE15
Mar 8, 2023Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTIS15
Mar 10, 2021Novel Antitumoral Use Of CabazitaxelAVENTIS PHARMA13